Ballicules.com

Adenosine

ADENOCARD

What it isEndogenous purine nucleoside acting at A1 to A3 receptors; IV bolus for supraventricular tachycardia.

Why this oneA half-life of seconds means a transient AV block that terminates re-entrant SVT and then vanishes.

What limits itGive it fast into a large vein with a flush, and warn the patient about the brief sense of doom. Dipyridamole potentiates it; theophylline blocks it.

FDA label

FDA dosingPopulationStartTargetMax
Paroxysmal supraventricular tachycardia (conversion)Adult6 mg rapid IV bolusIf no response in 1–2 min, 12 mg rapid IV bolus; may repeat 12 mg once12 mg per dose
Paroxysmal supraventricular tachycardia (conversion)Pediatric <50 kg0.05–0.1 mg/kg rapid IV bolusIncrease by 0.05–0.1 mg/kg each repeat until sinus rhythm0.3 mg/kg single dose
Paroxysmal supraventricular tachycardia (conversion)Pediatric ≥50 kgAdult dose (6 mg)12 mg if needed12 mg per dose

Renal Undefined

Hepatic Undefined

Doses greater than 12 mg are not recommended for adult or pediatric patients.

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy No animal or human studies; as a naturally occurring substance fetal effects not anticipated, but use during pregnancy only if clearly needed (former Category C).

Lactation Undefined

NO BOXED WARNINGS

Principal riskA brief but severe sense of doom; theophylline blocks it

Classes and tags

Clinical profile

Direct muscarinic antagonism0 / 4

Mechanism of action: Adenosine ballicule

Adenosine ballicule: receptor binding, kinetics and half-life diagram

Open Adenosine in the interactive console ↗

Memory aids: mascots and interaction avatars

Adenosine ADENOCARD mascot mnemonic cartoon
“A dino sign”

Open Adenosine in the interactive console ↗